Welcome to LookChem.com Sign In|Join Free

CAS

  • or

361444-66-8

Post Buying Request

361444-66-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (3R)-7-HYDROXY-N-[(2S)-1-[(3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYLPIPERIDIN-1-YL]-3-METHYLBUTAN-2-YL]-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXAMIDE

    Cas No: 361444-66-8

  • No Data

  • 1 Gram

  • Metric Ton/Day

  • Afine Chemicals Limited
  • Contact Supplier

361444-66-8 Usage

Uses

JDTic is a highly selective antagonist of κ-opioid receptor (KOR).

Biological Activity

ki = 0.3 nmjdtic is a selective opioid kappa receptor antagonist.at least three opioid receptor subtypes, μ, δ, and κ, are responsible for the modulation of a diverse array of biological events from nociception to immune regulation. the baisi of studying this complex receptor system is for the identification of both agonists and antagonists with high degree of receptor subtype selectivity.

in vitro

jdtic demonstrated high affinity for the κ receptor in the binding assay and highly potent and selective κ antagonism in the [35s]gtp-γ-s assay. jdtic showed a 16-fold improvement in its κ receptor ki value in the functional assay relative to the binding assay. in the [35s]gtp-γ-s functional assay, jdtic demonstrated a 3.4-fold increase in κ antagonist potency relative to the functional assay utilizing guinea pig membranes [1].

in vivo

jdtic was found to be able to dose-dependently block acute nicotineinduced antinociception in the tail-flick but not the hotplate test and did not attenuate morphine's antinociceptive effect significantly in either test. moreover, jdtic failed to block the expression of nicotine reward as measured by the conditioned place preference model. in contrast, jdtic attenuated the expression of both physical and affective nicotine withdrawal signs in mice[2].

references

[1] thomas jb,atkinson rn,rothman rb,fix se,mascarella sw,vinson na,xu h,dersch cm,lu y,cantrell be,zimmerman dm,carroll fi. identification of the first trans-(3r,4r)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. j med chem.2001 aug 16;44(17):2687-90.[2] jackson kj,carroll fi,negus ss,damaj mi. effect of the selective kappa-opioid receptor antagonist jdtic on nicotine antinociception, reward, and withdrawal in the mouse. psychopharmacology (berl).2010 jun;210(2):285-94.

Check Digit Verification of cas no

The CAS Registry Mumber 361444-66-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,1,4,4 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 361444-66:
(8*3)+(7*6)+(6*1)+(5*4)+(4*4)+(3*4)+(2*6)+(1*6)=138
138 % 10 = 8
So 361444-66-8 is a valid CAS Registry Number.

361444-66-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R)-7-hydroxy-N-[(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

1.2 Other means of identification

Product number -
Other names JDC

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:361444-66-8 SDS

361444-66-8Downstream Products

361444-66-8Relevant articles and documents

Identification of the first trans-(3R,4R)-Dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid κ receptor antagonist activity

Thomas,Atkinson,Rothman,Fix,Mascarella,Vinson,Xu,Dersch,Lu,Cantrell,Zimmerman,Carroll

, p. 2687 - 2690 (2001)

-

Kappa opioid receptor ligands

-

, (2008/06/13)

Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors relative to nor-BNI, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 361444-66-8